Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $9.91 and last traded at $9.89, with a volume of 31150 shares traded. The stock had previously closed at $9.72.
Wall Street Analysts Forecast Growth
Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a “strong-buy” rating in a research report on Friday, October 25th.
Get Our Latest Analysis on Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Stock Performance
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Recommended Stories
- Five stocks we like better than Fresenius SE & Co. KGaA
- Quiet Period Expirations Explained
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- With Risk Tolerance, One Size Does Not Fit All
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.